Skip to main content
Veterinary Medicines

DISTOMICIDE 250 mg/ml SOLUCION INYECTABLE

Authorised
  • Nitroxinil

Product identification

Medicine name:
DISTOMICIDE 250 mg/ml SOLUCION INYECTABLE
Active substance:
  • Nitroxinil
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Nitroxinil
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        63
        day
      • Milk
        no withdrawal period
    • Sheep
      • Meat and offal
        63
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AG08
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Ovejero S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.U.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 154 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/09/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/09/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/09/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."